Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Laurus Labs Limited, priced at $0.0247 per EA under NDC 42385094811. Its NADAC has been published 174 times since Mar 1, 2023.
Strength
850 mg/1
Manufacturer
Laurus Labs LimitedNDC
42385094811
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209882On Market Since
5/17/2021
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 174 times since Mar 1, 2023, and over the history we have for it it has declined 16.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0247 per EA |
|---|---|
| All-time high | $0.0297 (Mar 15, 2023) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0243 |
| Average price | $0.0245 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 174 |
| Tracking since | Mar 1, 2023 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Laurus Labs Limited, is $0.0247 per EA (NDC 42385094811), effective Jun 24, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 16.9%. It has been tracked across 174 weekly CMS publications since Mar 1, 2023.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Mar 1, 2023, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0297 (Mar 15, 2023), with a median of $0.0243 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
13 NADAC-published products share the same active ingredient, strength, and dosage form as METFORMIN HCL 850 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 42385094811) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification